tiprankstipranks
Trending News
More News >
Nosa Plugs AB (SE:NOSA)
:NOSA
Sweden Market
Advertisement

Nosa Plugs AB (NOSA) AI Stock Analysis

Compare
0 Followers

Top Page

SE:NOSA

Nosa Plugs AB

(NOSA)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
kr0.50
▼(-12.28% Downside)
The overall stock score is primarily impacted by significant financial challenges and bearish technical indicators. The company's ongoing losses and negative cash flow weigh heavily on its financial performance score. Additionally, the technical analysis suggests a lack of upward momentum, further impacting the overall score. The negative P/E ratio and absence of a dividend yield also contribute to a low valuation score.

Nosa Plugs AB (NOSA) vs. iShares MSCI Sweden ETF (EWD)

Nosa Plugs AB Business Overview & Revenue Model

Company DescriptionNosa Plugs AB, a medical technology company, manufactures and sells intranasal breathing products primarily in Europe and North America. Its products include NOSA plugs, such as NOSA odor control products for odor protection; NOSA microbial control products to reduce the exposure of viruses and bacteria by inhalation through the nose; and NOSA allergy filter that filters harmful airborne particles, such as pollen, pet dander, dust, and mold. The company was incorporated in 2014 and is based in Stockholm, Sweden.
How the Company Makes MoneyNosa Plugs AB generates revenue primarily through the sale of its electrical connectors and plugs, which are sold to various sectors, including automotive manufacturers, telecommunications companies, and electronics manufacturers. The company's revenue model is based on both direct sales to customers and partnerships with distributors who help reach a broader market. Key revenue streams include bulk orders from OEMs, smaller orders from retail clients, and custom connector solutions tailored to specific customer requirements. Additionally, NOSA has established significant partnerships with industry players, enabling collaborative product development and access to new markets, which further enhances its earning potential.

Nosa Plugs AB Financial Statement Overview

Summary
Nosa Plugs AB is facing significant financial challenges with ongoing losses impacting profitability. While revenue and gross profit have shown improvements, the company needs to address its negative net income and cash flow issues to achieve financial stability. The low leverage provides some stability but also highlights limited growth financing through debt.
Income Statement
45
Neutral
Nosa Plugs AB has shown a fluctuating revenue growth over the years with an increase from 2023 to 2024. The gross profit margin improved significantly in 2024, but the company still faces challenges with negative EBIT and net income margins. The consistent negative net profit margin highlights ongoing profitability issues.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio is relatively low, reflecting prudent financial leverage. However, the equity ratio has been decreasing, indicating a reduction in shareholder equity relative to total assets. The return on equity remains negative, reflecting continued losses, but the low debt level provides some financial stability.
Cash Flow
50
Neutral
Nosa Plugs AB has been experiencing negative free cash flow, although there was a substantial improvement in 2024 compared to 2023. The operating cash flow remains negative, indicating operational cash generation challenges. Cash flow from financing activities has helped maintain liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue18.20M16.10M10.39M6.85M5.85M1.37M
Gross Profit13.02M11.20M6.92M-13.64M-6.45M-103.59M
EBITDA-5.41M-8.45M-44.98M-7.59M-38.60M-204.69M
Net Income-7.65M-10.16M-46.55M-17.82M-58.56M-229.12M
Balance Sheet
Total Assets49.35M20.70M33.08M21.67M40.09M116.25M
Cash, Cash Equivalents and Short-Term Investments33.64M4.31M1.19M2.52M10.40M87.81M
Total Debt604.00K1.01M1.88M1.72M9.04M3.28M
Total Liabilities3.79M4.14M6.33M3.33M980.00K14.61M
Stockholders Equity45.56M16.56M26.75M6.70M39.10M101.64M
Cash Flow
Free Cash Flow-4.55M-14.70M-18.35M-5.19M-16.81M-79.14M
Operating Cash Flow-6.91M-10.03M-17.50M-5.13M-6.21M-69.96M
Investing Cash Flow-2.32M-4.71M14.55M-61.00K-52.20M-8.21M
Financing Cash Flow31.48M17.81M1.61M5.29M-119.00K139.27M

Nosa Plugs AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.57
Price Trends
50DMA
0.69
Negative
100DMA
0.75
Negative
200DMA
0.79
Negative
Market Momentum
MACD
-0.02
Positive
RSI
27.95
Positive
STOCH
19.37
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOSA, the sentiment is Negative. The current price of 0.57 is below the 20-day moving average (MA) of 0.68, below the 50-day MA of 0.69, and below the 200-day MA of 0.79, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 27.95 is Positive, neither overbought nor oversold. The STOCH value of 19.37 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NOSA.

Nosa Plugs AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
50
Neutral
€144.94M-3.93-27.22%16.38%35.72%
46
Neutral
kr89.80M-60.20%163.12%30.50%
44
Neutral
kr186.92M-19.9417.24%35.77%
41
Neutral
kr98.58M-253.54%36.15%26.67%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:NOSA
Nosa Plugs AB
0.57
-0.09
-13.64%
SE:SCIB
SciBase Holding AB
0.24
-0.18
-42.42%
SE:LXB
Luxbright AB
0.65
-0.28
-30.05%
SE:BRAIN
BrainCool AB
0.60
-0.89
-59.64%
SE:ARCOMA
Arcoma AB
7.58
-3.17
-29.49%
SE:NEOLA
Neola Medical AB
1.47
-0.53
-26.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 11, 2025